Manulife (Manufacturers Life Insurance)’s Stereotaxis STXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.5K Sell
19,267
-1,326
-6% -$2.91K ﹤0.01% 2771
2025
Q4
$47.4K Sell
20,593
-2,156
-9% -$5.74K ﹤0.01% 2825
2025
Q3
$70.7K Sell
22,749
-355
-2% -$920 ﹤0.01% 2841
2025
Q2
$49K Sell
23,104
-4,991
-18% -$10.1K ﹤0.01% 2889
2025
Q1
$49.4K Buy
+28,095
New +$59.9K ﹤0.01% 2836
2022
Q2
Sell
-22,811
Closed -$85.1K 3131
2022
Q1
$85.1K Sell
22,811
-5,590
-20% -$26.4K ﹤0.01% 2981
2021
Q4
$176 Sell
28,401
-1,134
-4% -$6.78K ﹤0.01% 2935
2021
Q3
$159K Sell
29,535
-927
-3% -$6.99K ﹤0.01% 3051
2021
Q2
$294K Buy
30,462
+3,251
+12% +$25.7K ﹤0.01% 2826
2021
Q1
$183K Sell
27,211
-3,637
-12% -$21.6K ﹤0.01% 2928
2020
Q4
$157K Buy
30,848
+2,116
+7% +$8.66K ﹤0.01% 2848
2020
Q3
$103K Hold
28,732
﹤0.01% 2794
2020
Q2
$130K Buy
+28,732
New +$116K ﹤0.01% 2662

Other funds holding STXS

Manulife (Manufacturers Life Insurance)'s STXS Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Stereotaxis (STXS) stake by 6.4% in Q1 2026, selling an estimated $2.91K and leaving 19,267 shares worth $35.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2771.

Manulife (Manufacturers Life Insurance) first reported a position in STXS in Q2 2020 and has held it in 13 quarters since. The position peaked at $294K in Q2 2021. 115 funds tracked by Wall St. Rank hold STXS as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 19,267 shares of Stereotaxis worth $35.5K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 1,326 Stereotaxis shares in Q1 2026, an estimated $2.91K.
  • Stereotaxis made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2771 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Stereotaxis in Q2 2020 and has held it in 13 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Stereotaxis position peaked at $294K in Q2 2021.
  • 115 funds tracked by Wall St. Rank held Stereotaxis as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.